JAGX (STOCKS)
Jaguar Health, Inc.
$0.370000
+0.001000 (+0.27%)
Prev close: $0.369000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Lisa A. Conte
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.08M
- Employees
- 49
- P/E (TTM)
- -0.01
- P/B (TTM)
- -0.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $11.51M |
| Benefits Costs and Expenses | $65.51M |
| Cost Of Revenue | $3.77M |
| Costs And Expenses | $57.42M |
| Gross Profit | $7.74M |
| Operating Expenses | $53.65M |
| Research and Development | $24.97M |
| Other Operating Expenses | $28.68M |
| Operating Income/Loss | -$45.91M |
| Income/Loss Before Equity Method Investments | -$53.84M |
| Income/Loss From Continuing Operations After Tax | -$54.00M |
| Income/Loss From Continuing Operations Before Tax | -$54.00M |
| Income/Loss From Equity Method Investments | -$162.00K |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Expense, Operating | $67.00K |
| Net Income/Loss | -$54.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$563.00K |
| Net Income/Loss Attributable To Parent | -$53.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$53.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$22.97 |
| Diluted Earnings Per Share | -$22.97 |
| Basic Average Shares | 2,332,401 |
| Diluted Average Shares | 2,332,401 |
| Assets | $38.32M |
| Current Assets | $20.35M |
| Inventory | $8.60M |
| Other Current Assets | $11.75M |
| Noncurrent Assets | $17.98M |
| Fixed Assets | $463.00K |
| Intangible Assets | $16.02M |
| Other Non-current Assets | $1.49M |
| Liabilities | $57.01M |
| Current Liabilities | $40.65M |
| Accounts Payable | $8.69M |
| Other Current Liabilities | $31.97M |
| Noncurrent Liabilities | $16.36M |
| Equity | -$18.69M |
| Equity Attributable To Noncontrolling Interest | -$1.40M |
| Equity Attributable To Parent | -$17.29M |
| Liabilities And Equity | $38.32M |
| Net Cash Flow From Operating Activities | -$23.69M |
| Net Cash Flow From Operating Activities, Continuing | -$23.69M |
| Net Cash Flow From Investing Activities | -$41.00K |
| Net Cash Flow From Investing Activities, Continuing | -$41.00K |
| Net Cash Flow From Financing Activities | $23.67M |
| Net Cash Flow From Financing Activities, Continuing | $23.67M |
| Net Cash Flow | -$57.00K |
| Net Cash Flow, Continuing | -$57.00K |
| Comprehensive Income/Loss | -$54.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$608.00K |
| Comprehensive Income/Loss Attributable To Parent | -$53.94M |
| Other Comprehensive Income/Loss | -$411.00K |